CONSTELLATION PHARMCETICLS I
(210373106)
Fondsberichterstattung Bestände von CONSTELLATION PHARMCETICLS I gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Casdin Capital LLC | 1,523,960 | $18,714,229k | Jun 30, 2019 | Aug 13, 2019 | |
| Orbimed Advisors LLC | 835,842 | $10,264k | Jun 30, 2019 | Aug 14, 2019 | |
| Hillhouse Capital Management Ltd | 317,921 | $3,904k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 183,600 | $2,255k | Jun 30, 2019 | Aug 14, 2019 | |
| Baker BROS Advisors LP | 133,333 | $1,637k | Jun 30, 2019 | Aug 14, 2019 | |
| Jasper Ridge Partners LP | 61,642 | $757k | Jun 30, 2019 | Aug 9, 2019 | |
| First Eagle Investment Management LLC | 28,464 | $350k | Jun 30, 2019 | Aug 13, 2019 | |
| Acadian Asset Management LLC | 4,984 | $61k | Jun 30, 2019 | Aug 8, 2019 |